cancer clinical trials for FPBCC CTO Studies

33 FPBCC CTO Studies clinical trials found. View a list of all cancer clinical trial types.

• A Phase III Randomized, Open-label Study of Rinatabart Sesutecan (Rina-S) Versus Treatment of Investigator's Choice (IC) in Patients With Platinum Resistant Ovarian Cancer

  Current Status: Open

  View links and contact information related to this clinical trial

• NRG-GY037: A Phase III Study of Induction Pembrolizumab and Chemotherapy Followed by Chemoradiation and Pembrolizumab Versus Chemoradiation and Pembrolizumab Both Followed by Pembrolizumab for High Risk Locally Advanced Cervical Cancer

  Current Status: Open

  View links and contact information related to this clinical trial

• A Multicenter, Randomized, Double-blind, Placebo-Controlled Phase II Study to Investigate the Efficacy and Safety of CYP-001 in Combination with Corticosteroids vs Corticosteroids Alone for the Treatment of High-Risk Acute Graft Versus Host Disease

  Current Status: Open

  View links and contact information related to this clinical trial

• Safety and Tolerability of Ziftomenib Combinations for the Treatment of KMT2A-rearranged or NPM1-mutant Relapsed/Refractory Acute Myeloid Leukemia

  Current Status: Open

  View links and contact information related to this clinical trial

• A Phase II Randomized Trial to Optimize GVHD Prophylaxis After Allogeneic Hematopoietic Cell Transplantation in Older Adults With Hematological Malignancies

  Current Status: Open

  View links and contact information related to this clinical trial

• Phase III Randomized Controlled Trial to Compare LYL314, a Dual Targeting CD19/CD20 CAR T-Cell Product Candidate, Versus Investigator's Choice of CD19 CAR T-Cell Therapy in Patients with Relapsed or Refractory Large B-Cell Lymphoma in the Second-Line Setting

  Current Status: Not Open

  View links and contact information related to this clinical trial

• Study of Subcutaneous Epcoritamab in Combination With Intravenous Rituximab and Oral Lenalidomide (R2) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Previously Untreated Follicular Lymphoma (EPCORE FL-2)

  Current Status: Open

  View links and contact information related to this clinical trial

• A First-In-Human Multicenter, Open-Label Study to Determine the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ABBV-319 in B-cell Malignancies

  Current Status: Open

  View links and contact information related to this clinical trial

• A Master Protocol to Evaluate the Long-Term Safety of Pirtobrutinib

  Current Status: Open

  View links and contact information related to this clinical trial

• Elacestrant Versus Standard Endocrine Therapy in Women and Men With Node-positive, Estrogen Receptor-positive, HER2-negative, Early Breast Cancer With High Risk of Recurrence-A Global, Multicenter, Randomized, Open-label Phase III Study

  Current Status: Open

  View links and contact information related to this clinical trial

• Randomized Phase II Study of Iberdomide Maintenance Therapy Following Idecaptagene Vicleucel CAR-T in Multiple Myeloma Patients

  Current Status: Open

  View links and contact information related to this clinical trial

• Resilience in Older Adults with Leukemia Receiving Initial Treatment: The ROAR-1 Study

  Current Status: Open

  View links and contact information related to this clinical trial

• Randomized, Open-label, Multicenter, Phase II Study Evaluating the Efficacy and Safety of Zilovertamab Vedotin (MK-2140) Plus R-CHP Versus Polatuzumab Vedotin Plus R-CHP in Treatment-naïve Participants With GCB Subtype of Diffuse Large B-cell Lymphoma (DLBCL)

  Current Status: Open

  View links and contact information related to this clinical trial

• Phase II Study of Dual Targeting of CD19 and CD20 Antigens Using Sequential CD19-directed CAR-T Cells Followed by Mosunetuzumab or Glofitamab in Relapsed or Refractory Diffuse Large B-cell or Transformed Follicular Lymphomas

  Current Status: Open

  View links and contact information related to this clinical trial

• A Phase III Clinical Trial Evaluating De-Escalation of Breast Radiation for Conservative Treatment of Stage I, Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer

  Current Status: Open

  View links and contact information related to this clinical trial

• MYELOMATCH, Master Screening and Reassessment Protocol for Tier Advancement in the NCI myeloMATCH Clinical Trials

  Current Status: Open

  View links and contact information related to this clinical trial

• Testing the Effects of Novel Therapeutics for Newly Diagnosed, Untreated Patients With High-Risk Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial)

  Current Status: Open

  View links and contact information related to this clinical trial

• A Phase Ib, Open Label, Global, Multicenter, Dose Determination, Randomized Dose Expansion Study to Determine the Maximum Tolerated Dose, Assess the Safety and Tolerability, Pharmacokinetics and Preliminary Efficacy of Iberdomide (CC-220) in Combination With R-CHOP-21 and CC-99282 in Combination With R-CHOP-21 for Subjects With Previously Untreated Aggressive B-cell Lymphoma

  Current Status: Open

  View links and contact information related to this clinical trial

• A Measurable Residual Disease (MRD) Driven, Phase II Study of Venetoclax Plus Chemotherapy for Newly Diagnosed Younger Patients With Intermediate Risk Acute Myeloid Leukemia: A Tier 1 MYELOMATCH Clinical Trial

  Current Status: Open

  View links and contact information related to this clinical trial

• A Phase III Randomized Study Comparing Talquetamab in Combination With Pomalidomide (Tal-P), Talquetamab in Combination With Teclistamab (Tal-Tec), and Investigator's Choice of Either Elotuzumab, Pomalidomide, and Dexamethasone (EPd) or Pomalidomide, Bortezomib, and Dexamethasone (PVd) in Participants With Relapsed or Refractory Myeloma Who Have Received 1 to 4 Prior Lines of Therapy Including an Anti-CD38 Antibody and Lenalidomide

  Current Status: Open

  View links and contact information related to this clinical trial

• Halt Aging in Survivors of Blood Cancers: the HALTAging-1 Study

  Current Status: Not Open

  View links and contact information related to this clinical trial

• A Phase I/II Study of Inhaled KB707 in Patients with Advanced Solid Tumor Malignancies Affecting the Lungs

  Current Status: Open

  View links and contact information related to this clinical trial

• A Phase II, Open-Label, Randomized, Multicenter Study to Evaluate the Safety and Efficacy of Axatilimab in Combination With Ruxolitinib in Participants With Newly Diagnosed Chronic Graft-Versus-Host Disease

  Current Status: Open

  View links and contact information related to this clinical trial

• Evaluation of Gut Microbiome Diversity in Breast Cancer Survivors Following Active Cancer Therapy

  Current Status: Open

  View links and contact information related to this clinical trial

• A Phase I, multicenter, oen-label study of UB-VV111 in combination with Rapamycin in relapsed or refractory (R/R) CD19+ B-Cell malignancies

  Current Status: Open

  View links and contact information related to this clinical trial

• Cognition in older adults with myeloma undergoing CAR-T therapy

  Current Status: Open

  View links and contact information related to this clinical trial

• A Phase III Randomized Study Comparing Teclistamab in Combination With Daratumumab SC and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab SC and Lenalidomide (Tal-DR) Versus Daratumumab SC, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma Who Are Either Ineligible or Not Intended for Autologous Stem Cell Transplant as Initial Therapy

  Current Status: Open

  View links and contact information related to this clinical trial

• A Randomized Phase III Trial of Continuous vs. Intermittent Maintenance Therapy with Zanubrutinib as Upfront Treatment in Older Patients with Mantle Cell Lymphoma (INTERCON)

  Current Status: Open

  View links and contact information related to this clinical trial

• A Pilot, Randomized, Double-blind, Placebo-controlled Study using Prebiotics to Improve Gut Microbiome Diversity After Autologous Cellular Therapy in Multiple Myeloma and Lymphoma: The PRIMAL Trial

  Current Status: Open

  View links and contact information related to this clinical trial

• A Phase I Multicenter, Open-Label Study to Determine the Recommended Dose and Evaluate the Safety and Preliminary Efficacy of BMS-986393 in Novel Combinations in Participants with Relapsed and/or Refractory Multiple Myeloma and Determine the Recommended Dose For Each Add On Investigational Component

  Current Status: Open

  View links and contact information related to this clinical trial

• Shorter Anthracycline-Free Chemo Immunotherapy Adapted to Pathological Response in Early Triple Negative Breast Cancer (SCARLET), A Randomized Phase III Study

  Current Status: Open

  View links and contact information related to this clinical trial

• ShortStop-HER2: Shortened Duration of Adjuvant Therapy in Patients With Early-Stage HER2+ Breast Cancer Who Achieve pCR After Neoadjuvant Chemotherapy With HER2 Blockade

  Current Status: Open

  View links and contact information related to this clinical trial

• A Phase III, Randomized Study of Daratumumab, Cyclophosphamide, Bortezomib and Dexamethasone (Dara-VCD) Induction Followed by Autologous Stem Cell Transplant or Dara-VCD Consolidation and Daratumumab Maintenance in Patients with Newly Diagnosed AL Amyloidosis

  Current Status: Open

  View links and contact information related to this clinical trial